Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08JHZ
|
|||
| Drug Name |
BLD-2660
|
|||
| Synonyms |
BLD 2660
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Coronavirus Disease 2019 (COVID-19) [ICD-11: 1D6Y] | Phase 2 | [1] | |
| Therapeutic Class |
Antiviral Agents
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | HUMAN calpain-1/calpain small subunit 1 heterodimer (CAPN1/CAPNS1) | Target Info | Inhibitor | [1], [2] |
| HUMAN calpain-2/calpain small subunit 1 heterodimer (CAPN2/CAPNS1) | Target Info | Inhibitor | [1], [2] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04334460) Safety and Antiviral Activity of BLD-2660 in COVID-19 Hospitalized Subjects. U.S. National Institutes of Health. | |||
| REF 2 | Blade is a leader in repairing tissue fibrosis and organ dysfunction | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.